Cargando…
Resolving erroneous reports in toxicology and therapeutic drug monitoring : a comprehensive guide /
The tools for detecting false positives, false negatives, and interference in interactions when testing and monitoring therapeutic drug useFor physicians monitoring a patient's progress, efficacy of treatment is often linked to a patient's response to medication. Determining whether a pati...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Hoboken :
John Wiley & Sons,
2012.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Mi 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_ocn798534225 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 120709s2012 nju ob 001 0 eng d | ||
| 040 | |a EBLCP |b eng |e pn |c EBLCP |d OCLCO |d N$T |d DG1 |d YDXCP |d OCLCQ |d OCLCF |d GWM |d RECBK |d OCLCQ |d OCLCO |d OCLCQ |d COO |d OCLCQ |d DEBBG |d DG1 |d LIP |d ZCU |d MERUC |d SAV |d OCLCQ |d ICG |d INT |d OCLCQ |d U3W |d OCLCQ |d U3G |d DKC |d OCLCQ |d UKAHL |d UX1 |d OCLCQ |d OCLCO |d OCLCQ |d OCL |d OCLCO |d OCLCL | ||
| 019 | |a 865012471 |a 992867612 |a 1087336167 | ||
| 020 | |a 9781118347867 |q (electronic bk.) | ||
| 020 | |a 1118347862 |q (electronic bk.) | ||
| 020 | |a 9781118347836 |q (electronic bk.) | ||
| 020 | |a 1118347838 |q (electronic bk.) | ||
| 020 | |a 9781118347850 |q (electronic bk.) | ||
| 020 | |a 1118347854 |q (electronic bk.) | ||
| 020 | |a 1118149653 | ||
| 020 | |a 9781118149652 | ||
| 020 | |z 9781118149652 |q (cloth) | ||
| 028 | 0 | 1 | |a EB00066742 |b Recorded Books |
| 029 | 1 | |a AU@ |b 000049858930 | |
| 029 | 1 | |a CHNEW |b 000940094 | |
| 029 | 1 | |a CHVBK |b 480203873 | |
| 029 | 1 | |a DEBBG |b BV042795371 | |
| 029 | 1 | |a DEBBG |b BV043394654 | |
| 029 | 1 | |a DEBBG |b BV044164226 | |
| 029 | 1 | |a DEBSZ |b 485022222 | |
| 029 | 1 | |a NZ1 |b 15900837 | |
| 029 | 1 | |a AU@ |b 000070478080 | |
| 035 | |a (OCoLC)798534225 |z (OCoLC)865012471 |z (OCoLC)992867612 |z (OCoLC)1087336167 | ||
| 050 | 4 | |a RM300 | |
| 060 | 4 | |a WB 330 | |
| 072 | 7 | |a MED |x 071000 |2 bisacsh | |
| 082 | 0 | 4 | |a 615.7/040724 |a 615.7040724 |
| 049 | |a UAMI | ||
| 100 | 1 | |a Dasgupta, Amitava, |d 1958- |1 https://id.oclc.org/worldcat/entity/E39PCjKXjRtBCw869yfhkdTq43 | |
| 245 | 1 | 0 | |a Resolving erroneous reports in toxicology and therapeutic drug monitoring : |b a comprehensive guide / |c Amitava Dasgupta. |
| 260 | |a Hoboken : |b John Wiley & Sons, |c 2012. | ||
| 300 | |a 1 online resource (696 pages) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 505 | 0 | |a Chapter 1 An Introduction to Tests Performed in Toxicology Laboratories; 1.1. INTRODUCTION; 1.2. ACETAMINOPHEN AND SALICYLATE ASSAYS; 1.3. ANALYSIS OF ALCOHOL; 1.4. THERAPEUTIC DRUG MONITORING; 1.5. ANALYTICAL METHODS USED FOR THERAPEUTIC DRUG MONITORING; 1.6. TESTING OF DRUGS OF ABUSE; 1.7. METHODS USED FOR TESTING OF DRUGS OF ABUSE; 1.8. CONCLUSIONS; Chapter 2 Challenges in Drugs of Abuse Testing; 2.1. INTRODUCTION; 2.2. WORKPLACE DRUG TESTING; 2.3. CHALLENGES OF MEDICAL VERSUS WORKPLACE DRUG TESTING; 2.4. CUT-OFF CONCENTRATIONS. | |
| 505 | 8 | |a 2.5. DRUGS NOT DETECTED IN DRUGS OF ABUSE TESTING PANELS2.6. ADULTERATION OF SPECIMENS AND NEGATIVE DRUGS OF ABUSE SCREEN; 2.7. DRUG TESTING IN ALTERNATIVE SPECIMENS; 2.8. CONCLUSIONS; Chapter 3 False-Positive Results Using Immunoassays for Drugs of Abuse Testing; 3.1. INTRODUCTION; 3.2. INTERFERENCES IN AMPHETAMINE IMMUNOASSAY; 3.3. INTERFERENCES WITH OPIATE IMMUNOASSAY; 3.4. FALSE-POSITIVE TEST RESULTS IN OTHER DRUGS OF ABUSE IMMUNOASSAYS; 3.5. CONCLUSIONS; Chapter 4 True-Positive Drugs of Abuse Test Results Due to Use of Prescriptions and Nonprescription Drugs; 4.1. INTRODUCTION. | |
| 505 | 8 | |a 4.2. POSITIVE AMPHETAMINE/METHAMPHETAMINE TEST RESULT4.3. TRUE-POSITIVE MARIJUANA RESULT; 4.4. TRUE-POSITIVE OPIATE TESTS DUE TO USE OF MEDICATIONS AND INGESTION OF PRODUCTS CONTAINING POPPY SEEDS; 4.5. TRUE-POSITIVE BENZODIAZEPINE TEST RESULTS; 4.6. VARIOUS FACTORS THAT PRODUCE A POSITIVE COCAINE RESULT; 4.7. CONCLUSIONS; Chapter 5 When Toxicology Report Is Negative in a Suspected Overdosed Patient: The World of Designer Drugs; 5.1. INTRODUCTION; 5.2. AMPHETAMINE-TYPE DESIGNER DRUGS; 5.3. OPIOID DESIGNER DRUG; 5.4. PHENCYCLIDINE ANALOGS AS DESIGNER DRUGS; 5.5. GHB AND ITS ANALOGS. | |
| 505 | 8 | |a 5.6. MARIJUANA ANALOGS AS DESIGNER DRUGS5.7. CONCLUSIONS; Chapter 6 Abuse of Magic Mushrooms, Peyote Cactus, Khat, and Solvents: No Readily Available Laboratory Tests; 6.1. INTRODUCTION; 6.2. MAGIC MUSHROOM ABUSE; 6.3. PEYOTE CACTUS: USE AND ABUSE; 6.4. ABUSE OF KHAT AND RELATED COMPOUNDS; 6.5. SOLVENT AND GLUE ABUSE; 6.6. CONCLUSIONS; Chapter 7 Limitations of Blood Alcohol Measurements Using Automated Analyzers and Breath Analyzers; 7.1. INTRODUCTION; 7.2. ALCOHOL METABOLISM; 7.3. MODERATE DRINKING VERSUS ALCOHOL ABUSE; 7.4. BLOOD ALCOHOL DETERMINATION. | |
| 505 | 8 | |a 7.5. BREATH ALCOHOL VERSUS BLOOD ALCOHOL DETERMINATION7.6. BLOOD ALCOHOL DETERMINATION; 7.7. CONCLUSIONS; Chapter 8 Role of the Laboratory in Detecting Other Poisoning, Including Pesticides, Ethylene Glycol, and Methanol; 8.1. INTRODUCTION; 8.2. PESTICIDE POISONING; 8.3. ORGANOPHOSPHATE AND CARBAMATE POISONING: MECHANISM OF POISONING AND SYMPTOMS; 8.4. CHALLENGES IN USING CHOLINESTERASE AS A DIAGNOSTIC TEST FOR ORGANOPHOSPHATE AND CARBAMATE POISONING; 8.5. METHANOL USE AND METHANOL POISONING; 8.6. ETHYLENE GLYCOL USE AND ETHYLENE GLYCOL POISONING; 8.7. CONCLUSIONS. | |
| 500 | |a Chapter 9 Poisoning with Warfarin and Superwarfarin: What Can Laboratory Testing Do? | ||
| 520 | |a The tools for detecting false positives, false negatives, and interference in interactions when testing and monitoring therapeutic drug useFor physicians monitoring a patient's progress, efficacy of treatment is often linked to a patient's response to medication. Determining whether a patient is taking the prescribed amount, the drug or dosage is effective, or the prescribed medication is interacting with other drugs can be determined through drug testing. Written as a guide for toxicologists, chemists, and health professionals involved in patient care, Resolving Erroneous Reports in Toxicolog. | ||
| 588 | 0 | |a Print version record. | |
| 504 | |a Includes bibliographical references and index. | ||
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a Drug monitoring. | |
| 650 | 0 | |a Drugs |x Toxicity testing. | |
| 650 | 0 | |a Drugs |x Side effects |x Reporting. | |
| 650 | 0 | |a Pharmacovigilance. | |
| 650 | 2 | |a Drug Monitoring | |
| 650 | 2 | |a Pharmacovigilance | |
| 650 | 2 | |a Product Surveillance, Postmarketing | |
| 650 | 6 | |a Pharmacovigilance. | |
| 650 | 6 | |a Médicaments |x Toxicité. | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Pharmacovigilance |2 fast | |
| 650 | 7 | |a Drugs |x Side effects |x Reporting |2 fast | |
| 650 | 7 | |a Drug monitoring |2 fast | |
| 650 | 7 | |a Drugs |x Toxicity testing |2 fast | |
| 758 | |i has work: |a Resolving erroneous reports in toxicology and therapeutic drug monitoring (Text) |1 https://id.oclc.org/worldcat/entity/E39PCFxDykGwXGXFKYQkW8Fmgq |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |a Dasgupta, Amitava. |t Resolving Erroneous Reports in Toxicology and Therapeutic Drug Monitoring : A Comprehensive Guide. |d Hoboken : John Wiley & Sons, ©2012 |z 9781118149652 |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=894396 |z Texto completo |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH24099698 | ||
| 938 | |a Askews and Holts Library Services |b ASKH |n AH24071744 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL894396 | ||
| 938 | |a EBSCOhost |b EBSC |n 467058 | ||
| 938 | |a Recorded Books, LLC |b RECE |n rbeEB00066742 | ||
| 938 | |a YBP Library Services |b YANK |n 8582286 | ||
| 938 | |a YBP Library Services |b YANK |n 7552080 | ||
| 938 | |a YBP Library Services |b YANK |n 12672214 | ||
| 994 | |a 92 |b IZTAP | ||